Amazon's strategic entry into the healthcare ecosystem is fundamentally driven by its core mission to improve the customer experience by enhancing convenience, providing clarity of cost and ensuring continuity of care. This approach directly targets the structural inefficiencies, administrative opacity, cost ambiguity and care fragmentation, that plague the traditional healthcare delivery model. Amazon views healthcare not as a fragmented collection of services but as a conti

The implementation of Polygenic Risk Scores (PRS) represents a fundamental advancement in quantifying the genetic liability for complex diseases. This approach acknowledges that common traits and disorders are influenced not by single variants, but by the cumulative effect of thousands of genetic markers, each contributing an attenuated but measurable impact. Understanding the mechanisms by which these scores are constructed, from basic summation models to sophisticated machi

The Medical Technology (MedTech) sector is currently navigating a period of profound transformation, solidifying its position as one of Venture Capital's (VC) most compelling frontiers. This assessment is validated by a powerful convergence of factors: the massive and resilient growth of the global healthcare market, the accelerating technological disruption catalysed by Artificial Intelligence (AI) and robotics, and the mandated economic shift toward value-based care (VBC).

Nelson Advisors Thought Leadership article 'Corporate Divestitures in European Healthcare Technology: Trends in 2025' has been referenced in DC Advisory's 'European Healthcare M&A finds its pulse' report dated October 14, 2025.

The European MedTech and HealthTech valuation landscape in October 2025 exhibits significant divergence by sub-sector, with a clear premium placed on innovative, high-growth, and recurring revenue business models, especially those powered by AI. Here is a breakdown of the valuation trends and multiples by sub-sector..

The current European HealthTech and MedTech landscape presents a compelling and timely opportunity for specialised Private Equity (PE) deployment, driven by a simultaneous market correction and entrenched structural fragmentation. Following the "exuberance" and peak valuations of the COVID-19-driven Venture Capital (VC) boom of 2021–2022, a significant shift in investor sentiment has occurred. High interest rates and inflation have elevated the cost of capital, forcing in

The transformation of the National Health Service (NHS) in England is defined by three interconnected "Enablers of Change": Digital Reform, Capital Investment and Workforce Reform. This strategic assessment establishes that the viability of the NHS’s foundational shifts, moving care from hospitals to communities, from analogue to digital, and from treatment to prevention is wholly contingent upon the successful, synergistic execution of these three enablers. The challenge is

The NHS England Medium Term Planning Framework (MTPF), officially published on 24 October 2025, establishes the operational and financial roadmap for Integrated Care Boards (ICBs) and providers for the three-year period spanning 2026/27 to 2028/29. This document represents a fundamental shift away from the legacy of crisis-driven, short-term annual planning toward a medium-to-long term system designed to foster local innovation and support long-term sustainability. The MTPF i

Nelson Advisors invited to join the 'Business Case for Ultra Personalisation' Debate at the Leaders in Health Summit 2025. The overarching question driving the Summit is: "Can Precision Breakthroughs, Regulatory Revolution & AI (Re)Humanise Healthcare?" The goal is to explore how to "Make medicine personable again."

Nelson Advisors will be speaking, presenting and chairing a number of panels at HealthTech conferences and events in October, November and December 2025. Please feel free to come and meet us in person or to book a meeting with us online please visit https://scheduler.zoom.us/nelson-advisors/meeting

The leading Consumer HealthTech M&A advisors in Europe operate effectively within the prescribed Dual Advisory Model, demonstrating competence in either global liquidity provision or deep technological specialisation. The Specialised Domain Experts, led by Nelson Advisors, with its exclusive focus on Consumer HealthTech, AI and its "Founders for Founders" operational credibility, provide the critical technical and operational diligence necessary.

The inaugural 2025: The State of AI in Healthcare Report from Menlo Ventures marks a critical inflection point, confirming that the healthcare industry has decisively moved past its entrenched reputation as a digital laggard. The analysis demonstrates a profound reversal, positioning the $4.9 Trillion industry as a leader in enterprise AI adoption. This accelerated commitment is quantified by key adoption metrics: the sector is now deploying AI at 2.2 times the rate of the br

The National Health Service (NHS) is currently undergoing a fundamental transformation, mandated by the government’s 10 Year Health Plan, which prioritises the shift from analogue to digital operations. This strategic commitment frames AI adoption not merely as an efficiency measure, but as a critical requirement for securing the NHS’s future financial sustainability. Key objectives of this ambitious plan include moving "from bricks to clicks" and granting patients control ov

The governance of Artificial Intelligence as a Medical Device (AIaMD) presents unique challenges related to algorithmic adaptivity, transparency, and assurance of continuous safety. The UK’s regulatory approach to this domain is strategically defined by a commitment to agility and innovation, leveraging existing sectoral regulators rather than relying on monolithic, preemptive legislation.

The single most significant key point from the Silicon Valley Bank (SVB) Future of HealthTech 2025 report is the dramatic shift of venture capital investment towards AI-enabled Provider Operations. The report suggests that the HealthTech sector is becoming more focused on solving business and operational inefficiencies using AI, rather than exclusively focusing on clinical care problems.